GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Operating Cash Flow per Share

Vectus Biosystems (ASX:VBS) Operating Cash Flow per Share : A$-0.02 (TTM As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Operating Cash Flow per Share?

Vectus Biosystems's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.01. Vectus Biosystems's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Vectus Biosystems's Operating Cash Flow per Share or its related term are showing as below:

ASX:VBS' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -43.9   Med: 8.5   Max: 30
Current: 27.4

During the past 8 years, Vectus Biosystems's highest 3-Year average Operating Cash Flow per Share Growth Rate was 30.00% per year. The lowest was -43.90% per year. And the median was 8.50% per year.

ASX:VBS's 3-Year OCF Growth Rate is ranked better than
77.33% of 1235 companies
in the Biotechnology industry
Industry Median: 3.6 vs ASX:VBS: 27.40

Vectus Biosystems Operating Cash Flow per Share Historical Data

The historical data trend for Vectus Biosystems's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Operating Cash Flow per Share Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Operating Cash Flow per Share
Get a 7-Day Free Trial -0.05 -0.13 -0.12 -0.13 -0.05

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.07 -0.06 -0.04 -0.01 -0.01

Competitive Comparison of Vectus Biosystems's Operating Cash Flow per Share

For the Biotechnology subindustry, Vectus Biosystems's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Price-to-Operating-Cash-Flow falls into.



Vectus Biosystems Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Vectus Biosystems's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )=Cash Flow from Operations (A: Jun. 2023 )/Shares Outstanding (Diluted Average) (A: Jun. 2023 )
=-2.353/47.952
=-0.05

Vectus Biosystems's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=-0.767/53.193
=-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectus Biosystems Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines